The PAK4 kinase in cell growth and transformation

PAK4 激酶在细胞生长和转化中的作用

基本信息

  • 批准号:
    7079336
  • 负责人:
  • 金额:
    $ 30.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-08-01 至 2009-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of the proposed experiments is to determine how the serine/threonine kinase Pak4 functions in the regulation of cell growth and transformation. Pak4 is an effector of the Rho GTPases Cdc42 and Rac, and was originally identified as a protein that functions in cytoskeletal organization. More recently, Pak4 was also shown to have important roles in controlling cell growth and survival. Pak4 is overexpressed in cancer cell lines, and Pak4 is highly transforming in established immortalized cell lines. In contrast, in primary cells Pak4 has a completely different function and triggers premature senescence rather than increased growth. In both respects Pak4 is similar to strong oncogenes such as oncogenic Ras, which are highly transforming in immortalized cells but inhibit growth in primary cells. Studying the role for Pak4 in cell growth is very important for understanding how Pak4 and Rho GTPases are associated with oncogenic transformation. The experiments in this proposal will take advantage of Pak4 null fibroblasts that have been generated in our lab, in order to study Pak4's role in the regulation of cell growth and transformation in immortalized cells, and premature senescence in primary cells. The following aims will be addressed: Aim 1.1. What role does Pak4 have in oncogenic transformation? Immortalized Pak4 null and control fibroblasts will be used to test the hypothesis that Pak4 is essential for transformation by Rho GTPases and their activators. We will also study the signaling pathways involved in Pak4 mediated transformation. Aim 1.2. What role does Pak4 have in the control of cell proliferation? The control of cell proliferation and transformation are closely associated. Here we will use the immortalized Pak4 null fibroblasts to test the hypothesis that Pak4 is required for cell cycle entry and proliferation in response to Rho GTPases. We will also determine whether cell cycle regulatory proteins function downstream to Pak4 during cell cycle progression. Aim 2. What signaling pathways mediate Pak4 induced premature senescence in primary cells? We will first test the hypothesis that Pak4 induced senescence in primary ceils is mediated by the ERK MAP Kinase, leading to induction of cell cycle regulatory proteins and subsequent inhibition of cell growth. We will also test the hypothesis that cytoskeletal regulatory proteins play an important role in Pak4 induced senescence. Finally, we will also determine whether Pak4 is required for oncogene induced senescence.
描述(由申请人提供):拟议实验的目的是确定丝氨酸/苏氨酸激酶Pak4在调节细胞生长和转化中的作用。Pak4是Rho gtpase Cdc42和Rac的效应物,最初被鉴定为在细胞骨架组织中起作用的蛋白质。最近,Pak4也被证明在控制细胞生长和存活方面具有重要作用。Pak4在癌细胞系中过表达,Pak4在已建立的永生化细胞系中高度转化。相比之下,在原代细胞中,Pak4具有完全不同的功能,引发过早衰老而不是促进生长。在这两方面,Pak4与强癌基因(如致癌基因Ras)相似,后者在永生化细胞中高度转化,但在原代细胞中抑制生长。研究Pak4在细胞生长中的作用对于了解Pak4和Rho gtpase如何与癌性转化相关非常重要。本课题的实验将利用我们实验室已经生成的Pak4 null成纤维细胞,研究Pak4在永生化细胞中调控细胞生长转化和原代细胞过早衰老中的作用。将讨论以下目标:目标1.1。Pak4在致癌转化中起什么作用?永生化Pak4缺失和对照成纤维细胞将用于验证Pak4对于Rho GTPases及其激活物的转化至关重要的假设。我们还将研究Pak4介导的转化所涉及的信号通路。目标1.2。Pak4在控制细胞增殖中起什么作用?细胞增殖和转化的控制是密切相关的。在这里,我们将使用永生化的Pak4缺失成纤维细胞来验证Pak4是应答Rho GTPases的细胞周期进入和增殖所必需的假设。我们还将确定在细胞周期进程中,细胞周期调节蛋白是否在Pak4的下游发挥作用。目标2。哪些信号通路介导Pak4诱导原代细胞过早衰老?我们将首先验证Pak4诱导原代细胞衰老是由ERK MAP激酶介导的,导致细胞周期调节蛋白的诱导和随后细胞生长的抑制。我们还将验证细胞骨架调节蛋白在Pak4诱导的衰老中发挥重要作用的假设。最后,我们还将确定Pak4是否在癌基因诱导的衰老中是必需的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AUDREY G MINDEN其他文献

AUDREY G MINDEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AUDREY G MINDEN', 18)}}的其他基金

Role of PAK5 in neurons and dendritic spines
PAK5 在神经元和树突棘中的作用
  • 批准号:
    6850783
  • 财政年份:
    2004
  • 资助金额:
    $ 30.45万
  • 项目类别:
Role of PAK5 in neurons and dendritic spines
PAK5 在神经元和树突棘中的作用
  • 批准号:
    6777735
  • 财政年份:
    2004
  • 资助金额:
    $ 30.45万
  • 项目类别:
Role of PAK5 in neurons and dendritic spines
PAK5 在神经元和树突棘中的作用
  • 批准号:
    7188029
  • 财政年份:
    2004
  • 资助金额:
    $ 30.45万
  • 项目类别:
Role of PAK5 in neurons and dendritic spines
PAK5 在神经元和树突棘中的作用
  • 批准号:
    7371038
  • 财政年份:
    2004
  • 资助金额:
    $ 30.45万
  • 项目类别:
Role of PAK5 in neurons and dendritic spines
PAK5 在神经元和树突棘中的作用
  • 批准号:
    7023870
  • 财政年份:
    2004
  • 资助金额:
    $ 30.45万
  • 项目类别:
SIGNALING BY A NEW MAMMALIAN STE20 RELATED KINASE
一种新的哺乳动物 STE20 相关激酶的信号传导
  • 批准号:
    6513320
  • 财政年份:
    1998
  • 资助金额:
    $ 30.45万
  • 项目类别:
SIGNALING BY A NEW MAMMALIAN STE20 RELATED KINASE
一种新的哺乳动物 STE20 相关激酶的信号传导
  • 批准号:
    6173345
  • 财政年份:
    1998
  • 资助金额:
    $ 30.45万
  • 项目类别:
SIGNALING BY A NEW MAMMALIAN STE20 RELATED KINASE
一种新的哺乳动物 STE20 相关激酶的信号传导
  • 批准号:
    6795160
  • 财政年份:
    1998
  • 资助金额:
    $ 30.45万
  • 项目类别:
The PAK4 kinase in cell growth and transformation
PAK4 激酶在细胞生长和转化中的作用
  • 批准号:
    6823374
  • 财政年份:
    1998
  • 资助金额:
    $ 30.45万
  • 项目类别:
The PAK4 kinase in cell growth and transformation
PAK4 激酶在细胞生长和转化中的作用
  • 批准号:
    6919247
  • 财政年份:
    1998
  • 资助金额:
    $ 30.45万
  • 项目类别:

相似海外基金

Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics
利用 PET 研究微塑料和纳米塑料的体内命运和健康影响
  • 批准号:
    10890903
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
亚型选择性代谢型谷氨酸受体 PET 配体
  • 批准号:
    10576674
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Neural Basis of Stress-Derailed Motherhood
压力脱轨母性的神经基础
  • 批准号:
    10666891
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Altered microglia states and microglia-endothelial cell axis in relation to white matter disease progression in VCID
VCID 中小胶质细胞状态和小胶质细胞内皮细胞轴的改变与白质疾病进展相关
  • 批准号:
    10738860
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
  • 批准号:
    10663717
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
糖原合成酶激酶 3 配体发现治疗阿尔茨海默病
  • 批准号:
    10637434
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Assessing Diffusion MRI Metrics for Detecting Changes of Synaptic Density in Alzheimer's Disease
评估弥散 MRI 指标以检测阿尔茨海默病突触密度的变化
  • 批准号:
    10739911
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
支持在吸烟者 2 期临床研究中评估 mGlu2 PAM SBP-9330 的安全性/毒理学、ADME 和 CMC 活动
  • 批准号:
    10829189
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Probing D2 and 5HT-2A mechanisms in early visual processing in V1
探索 V1 早期视觉处理中的 D2 和 5HT-2A 机制
  • 批准号:
    10605769
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
Develop in vivo PET imaging probes for ROCK2 as a biomarker of early Alzheimer's disease.
开发 ROCK2 的体内 PET 成像探针作为早期阿尔茨海默病的生物标志物。
  • 批准号:
    489145
  • 财政年份:
    2023
  • 资助金额:
    $ 30.45万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了